Olema Pharmaceuticals, Inc.

NASDAQ:OLMA

Biotechnology

Healthcare
$7.06 -2.70%

-$0.26 today

Market cap
$618.50M
Beta
2.00
P/E (TTM)
-5.1
EPS (TTM)
-$1.80
52W Low $4.02High $36.26

Volume 1.18M

Average 1.27M

OLMA Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

No reported Net Margin figures are available to summarize.

Net Margin history

Percent of revenue · from the income statement

No Net Margin data reported for this period type.

Net Margin vs competitors

How OLMA compares with its peers on the latest reported figures

OLMA Competitors Peer median
Net Margin for OLMA and competitors
Company Period LTM level YoY 3-year change
PBYIPuma Biotechnology, Inc.LTM Mar 202610.7% -5.6 pp+13.6 pp
OLMAOlema Pharmaceuticals, Inc.FY2025— ——
Peer median (excluding OLMA) 10.7%-5.6 pp+13.6 pp

Competitors are the stored peer set for OLMA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development51.1M82.27M86.14M124.52M157.7M
Selling, General & Admin20.39M24.71M18.82M17.74M21M
Operating Expenses71.49M106.99M104.96M142.26M178.7M
Depreciation & Amortization163K357K377K393K490K
EBITDA(70.93M)(104.43M)(96.28M)(129.08M)(161.96M)
EBITDA Margin—————
Operating Income(71.49M)(106.99M)(104.96M)(142.26M)(178.7M)
Operating Margin—————
Interest Income442K2.23M8.32M12.68M16.22M
Interest Expense—0—00
Other Income / Expenses395K2.2M8.31M12.78M16.25M
Income Before Tax(71.1M)(104.79M)(96.66M)(129.47M)(162.45M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(71.1M)(104.79M)(96.66M)(129.47M)(162.45M)
Net Margin—————
EPS (Basic)(1.79)(2.62)(2.14)(2.20)(1.87)
EPS (Diluted)(1.79)(2.62)(2.14)(2.20)(1.87)
Weighted Avg Shares39.52M40M45.25M58.74M87.01M
Weighted Avg Shares (Diluted)39.52M40M45.25M58.74M87.01M

Olema Pharmaceuticals, Inc.

NASDAQ:OLMA

Intrinsic Alpha fair value

Locked

Current Price

$7.06

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.